Cerebral board ousts CEO Kyle Robertson amid federal probe
May 18, 2022 at 17:47 PM EDT
Following accusations of overprescribing Adderall and a looming investigation by the Drug Enforcement Agency, the telemedicine firm is changing its leadership.